Zusammenfassung
Steroidbedingte Hypertonien repräsentieren nach den renalen Erkrankungen die häufigste Ursache der sekundären Hypertonie. Steroidhormone werden unterteilt in Glukokortikoide, Mineralokortikoide und Sexualsteroide. Die endogenen Glukokortikoide sind nicht selektiv und können auch mineralokortikoide Wirkungen aufweisen. Die Mehrzahl endogener Steroidhypertonien wird durch Nebennieren-oder Hypophysentumoren ausgelöst (Cushing-Syndrom, primärer Hyperaldosteronismus). In anderen Fällen steroidbedingter Hypertonie liegen isolierte Gendefekte im Steroidmetabolismus vor (Tabelle 4.4.1). Diese Defekte machen sich meist schon im Kindesalter bemerkbar und sollten früh diagnostiziert und spezifisch therapiert werden. Die Klassifizierung der Hypertonie im Kindesalter ist allerdings noch unklar, und es ist zu berücksichtigen, daß die Normwerte des Blutdrucks bei Kindern niedriger liegen, als bei Erwachsenen [Joint National Committee 1988].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agarwal AK, Monder C, Eckstein B, White PC (1989) Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem 264: 18.939-18.943
Agarwal AK, Mune T, Monder C, White PC (1995a) Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity. Biochim Biophys Acta 1.248: 70-74
Agarwal AK, Rogerson FM, Mune T, White PC (1995b) Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Genomics 29: 195 - 199
Aguilera G, Fujita K, Catt KJ (1981) Mechanisms of inhibition of aldosterone secretion by adrenocorticotropin. Endocrinology 108: 522 - 528
Ahlgren R, Yanase T, Simpson ER, Winter JS, Waterman MR (1992) Compound heterozygous mutations (Arg 239stop, Pro 342Thr) in the CYP17 (P45.017 alpha) gene lead to ambiguous external genitalia in a male patient with partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab 74: 667 - 672
Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: R11 - 17
Angeli A, Frairia R (1985) Ketokonazol therapy in Cushing’s disease. Lancet 1: 821
Armanini D, Karbowiak I, Krozowski Z, Funder JW, Adam WR (1982) The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111: 1.683-1.686
Armanini D, Karbowiak I, Funder JW (1983) Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf) 19: 609 - 612
Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268 - 275
Atkinson AB (1991) The treatment of Cushing’s syndrome. Clin Endocrinol (Oxf) 34: 507 - 513
August JT, Nelson D, Thorn G (1958) Response of normal subjects to large amounts of aldosterone. J Clin Invest 37: 1. 549
Axelrod L (1983) Inhibition of prostacyclin production mediates permissive effect of glucocorticoids on vascular tone. Lancet I: 904-906
Bateman A, Singh A, Kral T (1989) The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10: 92 - 112
Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335 - 344
Biason A, Mantero F, Scaroni C, Simpson ER, Waterman MR (1991) Deletion within the CYP17 gene together with insertion of foreign DNA is the cause of combined complete 17 alpha-hydroxylase/17,20-lyase deficiency in an Italian patient. Mol Endocrinol 5: 2.037-2.045
Biglieri EG, Herron MA, Brust N (1966) 17-hydroxylation deficiency in man. J Clin Invest 45: 1.946-1.954
Blachley JD, Knochel JP (1980) Tobacco chewer’s hypokalernia: licorice revisited. N Engl J Med 302: 784 - 785
Borst JGG, Ten Holt SP, De Vries LA, Molhuysen JA (1953) Synergistic action of liquorice and cortisone in Addison’s and Simmond’s desease. Lancet 1: 657 - 663
Bttner B, Schrauber H, Bernhardt R (1996) Engineering a mineralcorticoid-to a glucocorticoid-synthesizing cytochrome P450. J Biol Chem 271: 8.028-8.033
Boutroy M-J, Vert P, Ligny BH de, Miton A (1984) Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation. Lancet II: 935-936
Brandon DD, Markwick AJ, Chrousos GP, Loriaux DL (1989) Glucocorticoid resistance in humans and nonhuman primates. Cancer Res 49: 2.203-2.213
Brown RD, Gaunt R, Gisoldi E, Smith N (1972) The role of deoxycorticosterone in adrenal regeneration hypertension. Endocrinology 91: 921 - 924
Brown JJ, Lever AF, Robertson JIS, Beevers DG, Cummings AMM, Davies DL, Fraser R, Mason P, Morton JJ, Tree M (1979) Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension? Ann Clin Biochem 16: 380 - 388
Brown RW, Chapman KE, Edwards CR, Seckl JR (1993) Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology 132: 2.614-2.621
Bülow HE, Möbius K, Bähr V, Bernhardt R (1996) Molecular cloning and functional expression of the cytochrome P450 11/3-hydroxylase of the guinea pig. Biochem Biophys Res Commun 221: 304 - 312
Card WI, Mitchell W, Strong JA, Taylor NRW, Tompset SL, Wilson JMG (1953) Effects of liquorice and its derivatives on salt and water metabolism. Lancet 2: 663 - 668
Carey RM, Sen S, Dolan LM (1984) Idiopathic hyperaldosteronism: a possible role for aldosterone-stimulating factor. N Engl J Med 311: 94 - 100
Carson-Jurica MA, Schrader WT, O’Malley BW (1990) Steroid receptor family: structure and functions. Endocr Rev 11: 201 - 219
Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC (1987) Cloning of cDNA encoding steroid 11-hydroxylase (P450c11). Proc Natl Acad Sci USA 84: 7.193-7.197
Chung BC, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shively JE, Miller WL (1987) Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 84: 407 - 411
Clark BJ, Wells J, King SR, Stocco DM (1994) The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 269: 28.314-28.322
Conn JW (1955) Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3 - 17
Conn JW, Rovner DR, Cohen EL (1968) Liquorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA 205: 492-496
Connell JMC, Kenyon CJ, Corrie JE, Fraser R, Watt R, Lever AF (1986) Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia? Hypertension 8: 669 - 676
Connell JMC, Inglis GC, Fraser R, Jamieson A (1995) Dexamethason-suppressible hyperaldosteronism: clinical, biochemical and genetic relations. J Hum Hypertens 9: 505 - 509
Curnow KM, Pascoe L, White PC (1992) Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 6: 1.113-1.118
Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA 90: 4.552-4.556
Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50: 137 - 195
Danielson M, Dammstrom B (1981) The prevalence of secondary and curable hypertension. Acta Med Scand 209: 451 - 455
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889 - 895
Evans RM, Arriza JL (1989) A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron 2: 1.105-1.112
Fan YS, Sasi R, Lee C, Winter JS, Waterman MR, Lin CC (1992) Localization of the human CYP17 gene [cytochrome P450 (17 alpha)] to 10g24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics 14: 1.110-1.111
Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL (1993) Deletion of amino acids Asp487-Ser488Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 77: 489 - 493
Fardella CE, Hum DW, Homoki J, Miller WL (1994) Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 79: 160 - 164
Fevold HR, Lorence MC, McCarthy JL, Trant JM, Kagimoto M, Waterman MR, Mason JI (1989) Rat P450(17 alpha) from testis: characterization of a full-length cDNA encoding a unique steroid hydroxylase capable of catalyzing both delta 4- and delta 5-steroid-17,20-lyase reactions. Mol Endocrinol 3: 968 - 975
Fraser R, Connell JM, Budd PS, Corrie JE, Kenyon CJ (1991) The origin and significance of 18-hydroxycortisol: studies in hyperaldosteronism and in bovine adrenocortical cells in vitro. J Steroid Biochem Mol Biol 39: 839 - 850
Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583 - 585
Ganguly A, Grim CE, Weinberger MH (1981) Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism. N Engl J Med 305: 991 - 993
Ganguly A, Weinberger MH, Guthrie GP, Fineberg NS (1984) Adrenal steroid responses to ACTH in glucocorticoidsuppressible aldosteronism. Hypertension 6: 563 - 567
Geley S, Kapelari K, Jöhrer K, Peter M, Glatzl J, Vierhapper H, Schwarz S, Helmberg A, Sippell WG, White PC, Kotler R (1996) CYP11B1 mutations causing congenital adrenal hyperplasia due to 11-hydroxylase deficiency. J Clin Endocrinol Metab 81: 2.896-2.901
Gomez-Sanchez CE (1984) 18-Hydroxycortisol and 18-oxocortisol, steroids from the transitional zone. Endocr Res 10: 609-615
Gomez-Sanchez CE, Holland OB, Murry BA, Lloyd HA, Milewich L (1979) 19-nor-deoxycorticosterone: a potent mineralocorticoid isolated from the urine of rats with regenerating adrenals. Endocrinology 105: 708-711
Gomez-Sanchez EP, Fort C, Thwaites D (1992) Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 262: E96 - E99
Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL (1991) Clinical and pathological diversity of primary aldosteronism, including a new family variety. Clin Exp Pharmacol Physiol 18: 283 - 286
Gordon RD, Klemm SA, Tunny TJ, Stowasser M (1992) Primary aldosteronism: hypertension with a genetic basis. Lancet 340: 159 - 161
Gordon RD, Stowasser M, Klemm SA, Tunny TJ (1994) Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD (ed) Textbook of hypertension. Blackwell, Oxford London, pp 865 - 892
Griffing GT, Dale SL, Holbrook MM, Melby JC (1983) 19nor-desoxycorticosterone excretion in primary aldosteronism and low renin hypertension. J Clin Endocrinol Metab 56: 218-221
Grollman A, Harrison TR, Williams JR (1940) The effect of various sterol derivatives on the blood pressure of the rat. J Pharmacol Exp Ther 69: 149 - 155
Haak HR (1990) Mitotane therapy of adrenocortical carcinoma. N Engl J Med 323: 758
Hackenthal E, Paul M, Ganten D, Taugner R (1990) Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70: 1.067-1.116
Hall PF (1985) Trophic stimulation of steroidogenesis: in search of the elusive trigger. Recent Prog Horm Res 41: 1 - 31
Hall CE, Gomez-Sanchez CE (1986) Hypertensive potency of 18-oxocortisol in the rat. Hypertension 8: 317 - 322
Hall JE, Granger JP, Smith MJ, Premen AJ (1984) Role of renal hemodynamics and arterial pressure in aldosterone escape. Hypertension [Suppl I] 6: I183 - I192
Hamlet SM, Gordon RD, Gomez-Sanchez CE, Tunny TJ, Klemm SA (1988) Adrenal transitional zone steroids, 18oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent. Clin Exp Pharmacol Physiol 15: 317 - 322
Helmberg A, Ausserer B, Kofler R (1992) Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11-hydroxylase deficiency. J Clin Endocrinol Metab 75: 1.278-1.281
Hierholzer K, Castello R, Kobayashi N, Fromm M (1990) Sites and significance of renal corticosteroid metabolism. Int Congr Ser Excerpta Med 877: 67 - 75
Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 141: 1.589-1.593
Hoefnagels WHL, Kloppenborg PWC (1983) Antimineralocorticoid effects of dexamethasone in subjects treated with glycerrhetinic acid. J Hypertens [Suppl 2] 1: 313 - 315
Hollenberg NK, Chenitz WR, Adams DF, Williams GH (1974) Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54: 34 - 42
Hollenberg NK, Williams GH, Burger B (1975) The influence of potassium on the renal vasculature and the adrenal, and their responsiveness to angiotensin II in normal man. Clin Sci (Colch) 49: 527 - 534
Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ (1992) Canadian mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet 89: 95 - 96
Imai T, Globerman H, Gertner JM, Kagawa N, Waterman MR (1993) Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Biol Chem 268: 19.681-19.689
Ishii-Ohba H, Matsumura R, Inano H, Tamaoki B (1984) Contribution of cytochrome b5 to androgen synthesis in rat testicular microsomes. J Biochem (Tokyo) 95: 335 - 343
Jöhrer K, Geley S, Kapelari K, White PC, Kofler R (1994) CYP11B1 mutations causing classic or non-classic congenital adrenal hyperplasia. Programm and abstracts, IX International congress on hormonal steroids, September 24-29, Dallas, Texas, p 101
Joint National Committee (1988) The 1988 report of the joint national commitee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 148: 1.023-1.038
Jones AW, Hart RG (1975) Altered ion transport in aortic smooth muscle during DOCA hypertension in the rat. Circ Res 37: 333 - 342
Jones MT, Gillham B (1988) Factors involved in the regulation of adrenocorticotropic hormone/ß-lipotropic hormone. Physiol Rev 68: 743 - 818
Kagimoto M, Winter JS, Kagimoto K, Simpson ER, Waterman MR (1988) Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alphahydroxylase/17,20 lyase deficiency. Mol Endocrinol 2: 564 - 570
Kapelari K, Geley S, Jöhrer K, Wozak E, Glatzl J, Peter M, Sippell WG, Kofler R (1994) Identification of molecular defects in congenital adrenal hyperplasia due to 11-hydroxylase deficiency. Exp Clin Endocrinol [Suppl 1] 102: 45
Kater CE, Biglieri EG (1994) Disorders of steroid 17-hydroxylase deficiency. Endocrinol Metab Clin North Am 23: 341 - 357
Kato S, Haji M, Yanase T, Nawata H, Kato K, Ibayashi H (1988) A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma. Endocrinol Jpn 35: 311 - 320
Kawamoto T, Matsuuchi Y, Toda K, Miyahara K, Yokoyama Y, Nakao K, Hosoda K, Yamamoto Y, Imura H, Shizuta Y (1990) Cloning of cDNA and genomic DNA for human cytochrome P-45010. FEBS Lett 269: 345 - 349
Kawamoto T, Matsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Onishi T, Ichikawa Y, Nakao K, Imura H, Ulick S, Shizuta Y (1992) Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci USA 89: 1.458-1.462
Kaye TB, Crapo L (1990) The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112: 434 - 444
Kenyon CJ, Saccoccio NA, Morris DJ (1984) Aldosterone effects on water and electrolyte metabolism. J Endocrinol 199: 93 - 100
Kobayashi N, Schulz W, Hierholzer K (1987) Corticosteroid metabolism in rat kidney in vitro. IV. Subcellular, sites of 11 beta-hydroxysteroid dehydrogenase activity. Pflugers Arch 408: 46 - 53
Kominami S, Shinzawa K, Takemori S (1982) Purification and some properties of cytochrome P-450 specific for steroid 17 alpha-hydroxylation and C17-C20 bond cleavage from guinea pig adrenal microsomes. Biochem Biophys Res Commun 109: 916 - 921
Kominami S, Ogawa N, Morimune R, De-Ying H, Takemori S (1992) The role of cytochrome b5 in adrenal microsomal steroidogenesis. J Steroid Biochem Mol Biol 42: 57 - 64
Kornel L (1993) The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance. J Steroid Biochem Mol Biol 45: 195 - 203
Krieger DT (1983) Physiopathology of Cushing’s disease. Endocr Rev 4: 22 - 43
Krozowski ZS, Funder JW (1983) Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6.056-6.060
Krozowski ZS, Albiston AL, Obeyesekere VR, Andrews RK, Smith RE (1995) The human 11 beta-hydroxysteroid dehydrogenase type II enzyme: comparisons with other species and localization to the distal nephron. J Steroid Biochem Mol Biol 55: 457 - 464
Laflamme N, Leblanc JF, Mailloux J, Faure N, Labrie F, Simard J (1996) Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patients. J Clin Endocrinol Metab 81: 264 - 268
Lamberts SWJ (1990) Endogeneous glucocorticoid resistance and therapy with glucocorticoid receptor antagonists. In: Allolio B, Schulte HM (Hrsg) Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart New York, S 26 - 31
Lifton RP (1996) Lecture. 16th Scientific Meeting of the ISH, Glasgow
Lifton RP, Hopkins PN, Williams RR, Hollenberg NK, Williams GH, Dluhy RG (1989) Evidence for heritability of non-modulating essential hypertension. Hypertension 13: 884 - 889
Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill Jr JR, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kaufman C, Stockigt JR, Ulick S, Lalouel JM (1992 a) Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 2: 66-74
Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992 b) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265
Lin D, Harikrishna JA, Moore CC, Jones KL, Miller WL (1991) Missense mutation serine106proline causes 17 alpha-hydroxylase deficiency. J Biol Chem 266: 15.992-15.998
Lin D, Black SM, Nagahama Y, Miller WL (1993) Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. Endocrinology 132: 2.498-2.506
Luton JP (1990) Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med 322: 1.195-1.201
Mahesh VB, Ulrich F (1960) Metabolism of cortisol and cortisone by various tissues and subcellular particles. J Biol Chem 235: 356 - 360
Malee MP, Mellon SH (1991) Zone-specific regulation of two messenger RNAs for P450c11 in the adrenals of pregnant and nonpregnant rats. Proc Natl Acad Sci USA 88: 4.731-4.735
Mazzocchi G, Malendowicz LK, Rebuffat P, Robba C, Gottardo G, Nussdorfer GG (1986) Short-and long-term effects of ACTH on the adrenal zona glomerulosa of the rat. Cell Tissue Res 243: 303 - 310
Melby JC (1991) Diagnosis of hyperaldosteronism. Endocrinol Metab Clin North Am 20: 247 - 255
Mercer WR, Krozowski ZS (1992) Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130: 540-543
Miyahara K, Kawamoto T, Mitsuuchi Y, Toda K, Imura H, Gordon RD, Shizuta Y (1992) The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity. Biochem Biophys Res Commun 189: 885 - 891
Monder C, Lakshmi V (1990) Corticosteroid 11 beta-dehydrogenase of rat tissues: immunological studies. Endocrinology 126: 2.435-2.443
Monder C, White PC (1992) 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 47: 187-271
Monno S, Ogawa H, Date T, Fujioka M, Miller WL, Kobayashi M (1993) Mutation of histidine 373 to leucine in cytochrome P450c17 causes 17 alpha-hydroxylase deficiency. J Biol Chem 268: 25.811-25.817
Mornet E, Dupont J, Vitek A, White PC (1989) Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-45011). J Biol Chem 264: 20. 961-20. 967
Morton JJ, Kenyon CJ, Beattie EC (1990) Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats. J Hypertens 8: 1.021-1.026
Mukai K, Mitani F, Shimada H, Ishimura Y (1995) Involvement of an AP-1 complex in zone-specific expression of the CYP11B1 gene in the rat adrenal cortex. Mol Cell Biol 15: 6.003-6.012
Müller J (1988) Monographs on endocrinology, vol 29. Regulation of aldosterone biosynthesis: physiological and clinical aspects. Springer, Berlin Heidelberg New York
Müller J (1995) Aldosterone: the minority hormone of the adrenal cortex. Steroids 60: 2 - 9
Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541 - 544
Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10: 394 - 399
Naiki Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Toda K, Orii T, Imura H, Shizuta Y (1993) A nonsense mutation (TGG [Trp116]TAG [Stop]) in CYP11B1 causes steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 77: 1.677-1.682
Nakagawa Y, Yamada M, Ogawa H, Igarashi Y (1995) Missense mutation in CYP11B1 (CGA[Arg384]GGA[Gly]) causes steroid 11-hydroxylase deficiency. Eur J Endocrinol 132: 286 - 289
Nakajin S, Shinoda M, Hall PF (1983) Purification and properties of 17 alpha-hydroxylase from microsomes of pig adrenal: a second C21 side-chain cleavage system. Biochem Biophys Res Commun 111: 512 - 517
Naray-Fejes-Toth, Fejes-Toth G (1990) Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol 259: F672 - F678
Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) The P450 super-family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1 - 42
New MI, Peterson RE (1967) A new form of congenital adre- nal hyperplasia. J Clin Endocrinol Metab 27: 300 - 305
New MI, Levine LS (1977) An unidentified ACTH-stimulable adrenal steroid in childhood hypertension. In: New MI, Levine LS (eds) Juvenile hypertension. Raven Press, New York, pp 143 - 163
New MI, Borelli P (eds) (1986) Dexamethasone-suppressible Hyperaldosteronism. Serono Symposia, Rome
New MI, Levine LS, Biglieri EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 44: 924 - 933
Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC (1993) Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Metab 77: 687 - 691
Nussey SS (1988) The combined use of sodium valproate and metyrapone in the treatment of Cushing’s syndrome. Clin Endocrinol (Oxf) 28: 373 - 380
Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee SM, Lightner E, Witte M, New MI (1981) Adrenal glomerulosa function in patients with dexamethasonesuppressible hyperaldosteronism. J Clin Endocrinol Me-tab 53: 158 - 164
Ohtani R, Yayama K, Takano M, Itoh N, Okamoto H (1992) Stimulation of angiotensinogen production in primary cultures of rat hepatocytes by glucocorticoid, cyclic adenosine 3′,5′-monophosphate, and interleukin-6. Endocrinology 130: 1.331-1.338
Okamoto M (1996) Cytochrome P450 (11/3): ectopic expression in oocyte and its physiological implication. Scientific programm and abstracts. Seventh conference on the adrenal, June 27-30: Crieff, Scotland, p 29
Onoda M, Hall PF (1982) Cytochrome b5 stimulates purified testicular microsomal cytochrome P-450 (C21 side-chain cleavage) Biochem Biophys Res Commun 108: 454 - 460
Orth DN (1995) Cushing’s syndrome. N Engl J Med 332: 791 - 803
Pascoe L, Curnow KM (1995) Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids 60: 22 - 27
Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC (1992) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89: 8.327-8.331
Paul M, Rettig R, Talsness CE, Zintz M, Yanagisawa M (1994) Transgenic rats expressing the human endothelin-2 gene: a new model to study endothelin regulation in vivo (abstract). J Hypertens [Suppl 3] 12: S72
Peters J (1995) Molecular basis of human hypertension: role of angiotensin. Baillires Clin Endocrinol Metab 9: 657 - 678
Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 6: 439 - 448
Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR (1990) Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348: 166 - 168
Plotz C, Knowlten A, Ragan C (1952) The natural history of Cushing’s syndrome. Am J Med 13: 597 - 614
Quinn SJ, Williams GH (1988) Regulation of aldosterone secretion. Annu Rev Physiol 50: 409 - 426
Reevers F (1946) Heft succus liqueritiae een genezende werking op de maagzweer? Ned Tijdschr Geneeskd 90: 135 - 137
Reevers F (1948) Behandeling van uleus ventriculi in uleus duodenum met succus liqueritiae. Ned Tijdschr Geneeskd. 92: 2.968-2.971
Rumsby G, Skinner C, Lee HA, Honour JW (1993) Combined 17 alpha-hydroxylase/17,20-lyase deficiency caused by heterozygous stop codons in the cytochrome P450 17 alpha-hydroxylase gene. Clin Endocrinol (Oxf) 39: 483 - 485
Rundle SE, Funder JW, Lakshmi V, Monder C (1989) The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies. Endocrinology 125: 1.700-1.704
Rusvai E, Naray-Fejes-Toth A (1993) A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268: 10.717-10.720
Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T (1994) Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension 23: 25 - 30
Schafer AJ, Hawk CT (1992) Regulation of Na+-channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int 41: 255 - 268
Schimmer BP (1980) Cyclic nucleotides in hormonal regulation of adrenocortical function. Adv Cycl Nucleotide Res 13: 181 - 214
Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62: 1.217-1.226
Schulz W, Kobayashi N, Siebe H, Hierholzer K (1987) 11-hydroxysteroid dehydrogenase (11-HSD) - its function in renal corticosteroid metabolism. In: Kovacevic Z, Guder WG (eds) Molecular nephrology: biochemical aspects of kidney function. de Gruyter, Berlin New York, pp 361-367
Simard J, Sanchez R, Durocher F, Rheaume E, Turgeon C, Labrie Y, Luu-The V, Mebarki F, Morel Y, de-Launoit Y, Labrie F (1995) Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family. J Steroid Biochem Mol Biol 55: 489 - 505
Simpson ER, Waterman MR (1988) Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50: 427 - 440
Skinner CA, Rumsby G (1994) Steroid 11-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Hum Mol Genet 3: 377 - 378
Skinner CA, Rumsby G, Honour JW (1996) Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene. J Clin Endocrinol Metab 81: 2.389-2.393
Skouby SO, Andersen O, Saubrey N, Kuhl C (1987) Oral contraception and insulin sensitivity in vivo: assessment in normal woman and women with previous gestational diabetes. J Clin Endocrinol Metab 64: 519 - 523
Smith DF, Toft DO (1993) Steroid receptors and their associated proteins. Mol Endocrinol 7: 4 - 11
Stalla GK, Müller OA (1990) Pharmakotherapie des Cushing Syndroms. In: Allolio B, Schulte HM (Hrsg) Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart New York, S 98 - 108
Stewart PM (1994) 11 beta-hydroxysteroid dehydrogenase. Baillieres Clin Endocrinol Metab 8: 357-378
Stewart PM, Mason JI (1995) Cortisol to cortisone: gluco- corticoid to mineralocorticoid. Steroids 60: 143 - 146
Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR (1987) Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821 - 824
Stewart PM, Whorwood CB, Mason JI (1995) Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol 55: 465 - 471
Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347: 88 - 91
Stocco DM, Clark BJ (1996) Role of the steroidogenic acute regulatory protein ( StAR) in steroidogenesis. Biochem Pharmacol 51: 197-205
Stowasser M, Bachmann AW, Jonsson JR, Tunny TJ, Klemm SA, Gordon RD (1995) Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. J Hypertens 13: 1.610-1.613
Sugihara N, Shimizu M, Kita Y, Shimizu K, Ino H, Miyamori I (1992) Cardiac characteristics and postoperative courses in Cushing’s syndrome. Am J Cardiol 69: 1.475-1.480
Sutherland DJ, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95: 1.109-1.119
Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI (1993) Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. J Clin Endocrinol Metab 77: 98 - 102
Takeda K, Bunag RD (1980) Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 2: 97 - 101
Tannin GM, Agarwal AK, Monder C, New MI, White PC (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 266: 16.653-16.658
Tonolo G, Fraser R, Connell JMC, Kenyon CJ (1988) Chronic low-dose infusions of dexamethasone in rats: effects on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens 6: 25 - 31
Toyota N, Monno S, Kobayashi T (1993) Two-bp deletion in exon 5 of CYP17 gene in a family with 17-hydroxylase deficiency. Nippon Naibungi Gakkai Zasshi 69: 295
Tsigelny I, Baker ME (1995) Structures important in mammalian 11 beta-and 17 beta-hydroxysteroid dehydrogenases. J Steroid Biochem Mol Biol 55: 589 - 600
Turpie AGG, Thomson TJ (1965) Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut 6: 591 - 594
Ulick S, Ramirez LC, New MI (1977) An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab 44: 799 - 802
Ulick S, Chan CK, Gill JR Jr, Gutkin M, Letcher L, Mantero F, New MI (1990) Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 71: 1.151-1.157
Vallotton MB (1996) Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol (Oxf) 45: 47 - 52
Viard I, Hall SH, Jaillard C, Berthelon MC, Saez JM (1992) Regulation of c-fos, c-jun and jun-B messenger ribonucleic acids by angiotensin-II and corticotropin in ovine and bovine adrenocortical cells. Endocrinology 130: 1.193-1.200
Wada A, Okamoto M, Nonaka Y, Yamano T (1984) Aldosterone biosynthesis by a reconstituted cytochrome P-450 11 beta system. Biochem Biophys Res Commun 119: 365 - 371
Watson JD, Gilman M, Witkowski J, Zoller M (1993) Rekombinierte DNA, 2. Aufl. Spektrum, Heidelberg
Weinberger MH, Grim CE, Hollifield JW (1979) Primary aldosteronism. Diagnosis, localization, and treatment. Ann Intern Med 90: 386-395
Weir RJ, Davies DL, Fraser R, Morton JJ, Tree M, Wilson A (1975) Contraceptive steroids and hypertension. J Steroid Biochem 6: 961 - 964
Werder E, Zachmann M, Vollmin J (1974) Unusual steroid excretion in a child with low renin hypertension. Res Steroids 6: 385 - 389
White PC, New MI, Dupont B (1987) Congenital adrenal hyperplasia (1). N Engl J Med 316: 1.519-1.524
White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A (1991) A mutation in CYP11B1 (Arg448His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 87: 1.664-1.667
White PC, Curnow KM, Pascoe L (1994) Disorders of ste- roid 11-hydroxylase isozymes. Endocr Rev 15: 421-438
Whitworth JA (1987) Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Kidney Int 31: 1.213-1.224
Whitworth CE, Fleming S, Cumming AD, Morton JJ, Burns NJT, Williams BC, Mullins JJ (1994) Spontaneous development of malignant phase hypertension in transgenic ren-2 rats. Kidney Int 46: 1.528-1.532
Williams GH, Hollenberg NK (1991) Functional derangements in the regulation of aldosterone secretion in hypertension. Hypertension [Suppl III] 18: III-143-III-149
Williams GH, Dluhy RG (1994) Diseases of the adrenal cortex. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds) Principles of internal medicine. McGraw-Hill, New York, pp 1.953-1. 976
Wilson SC, Oakey RE, Scott JS (1988) Steroid metabolism in testes of patients with incomplete masculinization due to androgen insensitivity or 17 beta-hydroxysteroid dehydrogenase deficiency and normally differentiated males. J Steroid Biochem 29: 649 - 655
Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CH, Hanauske Abel HM, Wie JQ, Hertecant J, Moran A, Neiberger RE, Williamson-Balfe J, Fattah A, Dane-man D, Licholai T, New MI (1995 a) Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehy-drogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 3.145-3.150
Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, RazzaghyAzar M, Harbison MD, Wie JQ, Shackleton CH, Funder JW, New MI (1995 b) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 2.263-2.266
Winterberg H, Vetter H (1983) Die Behandlung des primären Aldosteronismus mit Trilostan. Schweiz Med Wochenschr 113: 1.735-1.738
Wisgerhof M, Carpenter PC, Brown RD (1978) Increased sensitivity to angiotensin II in idiopathic hyperaldosteronism. J Clin Endocrinol Metab 47: 938 - 943
Woodland E, Tunny TJ, Hamlet SM, Gordon RD (1985) Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism. Clin Exp Pharmacol Physiol 12: 245 - 248
Woods JW (1988) Oral contraceptives and hypertension. Hypertension [Suppl II] 11: 11 - 15
Yanagibashi K, Hall PF (1986) Role of electron transport in the regulation of lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes. J Biol Chem 261: 8. 429-8. 433
Yanase T (1995) 17-Hydroxylase/17,20-lyase defects. J Steroid Biochem Mol Biol 53: 153-157
Yanase T, Kagimoto M, Matsui N, Simpson ER, Waterman MR (1988) Combined 17 alpha-hydroxylase/17,20-lyase deficiency due to a stop codon in the N-terminal region of 17 alpha-hydroxylase cytochrome P-450. Mol Cell Endocrinol 59: 249 - 253
Yanase T, Kagimoto M, Suzuki S, Hashiba K, Simpson ER, Waterman MR (1989) Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20lyase deficiency. J Biol Chem 264: 18. 076-18. 082
Yanase T, Sanders D, Shibata A, Matsui N, Simpson ER, Waterman MR (1990) Combined 17 alpha-hydroxylase/ 17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P45.017 alpha (CYP17) gene. J Clin Endocrinol Metab 70: 1.325-1.329
Yanase T, Simpson ER, Waterman MR (1991) 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12: 91-108
Yanase T, Waterman MR, Zachmann M, Winter JS, Simpson ER, Kagimoto M (1992) Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region [Arg(496)Cys, Gln(461)Stop] actually cause combined 17 alpha-hydroxylase/17,20-lyase deficiency. Biochim Biophys Acta 1.139: 275-279
Zuber MX, Simpson ER, Waterman MR (1986) Expression of bovine 17-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 234: 1. 258-1. 261
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Peters, J., Hampf, M., Peters, B., Bernhardt, R. (1998). Molekularbiologie, Klinik und Therapie steroidbedingter Hypertonien. In: Ganten, D., Ruckpaul, K. (eds) Herz-Kreislauf-Erkrankungen. Handbuch der Molekularen Medizin, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80360-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-80360-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80361-1
Online ISBN: 978-3-642-80360-4
eBook Packages: Springer Book Archive